Buyside Needs Tech, Exemptions To Clear OTC Derivatives
Buy-side firms will need new technology and regulatory exemptions before they can effectively access central counterparty clearing (CCP) platforms for over-the-counter derivatives directly, according to Ila Eckhoff, director at BlackRock.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts